ArticleTherapeutic advances in hematology2026
Real-world efficacy and tolerability of ixazomib-based combination therapies in advanced multiple myeloma and other plasma cell neoplasms.
Xiang Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.